Clinical Trials Logo

Clinical Trial Summary

Removal of the uterus (hysterectomy) is the most commonly performed major gynaecological procedure in women. Obstetricians and gynaecologist (O&G) surgeons conduct the majority of hysterectomies. Surgical approaches to removal of the uterus include laparoscopic hysterectomy, vaginal hysterectomy with or without laparoscopic assistance and open hysterectomy through an abdominal incision. It is widely accepted that laparoscopic hysterectomy and vaginal hysterectomy are less invasive procedures, cause fewer surgical complications, less postoperative pain, require a shorter hospital stay and are associated with quicker recovery than abdominal hysterectomy. In Australia and despite the evidence, Total Abdominal Hysterectomy (TAH) rates are unreasonably high (~40%) and only 13% of all hysterectomies are done via Total Laparoscopic Hysterectomy (TLH) in Australia. This study aims to implement and evaluate a training program in TLH for gynaecologists. The potential benefits to the community are: - A reduction in the incidence of overall surgical adverse events in patients receiving a hysterectomy - A reduction in the length of hospital stay for patients requiring a hysterectomy - A reduction in the direct hospital costs for hysterectomy


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03617354
Study type Observational
Source Queensland Centre for Gynaecological Cancer
Contact
Status Completed
Phase
Start date March 29, 2017
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT02249390 - Assisted Reproductive Technology Survey (ART Survey)
Unknown status NCT02213627 - Use of Corifolitropin Alfa in Oocyte Donors Phase 4
Terminated NCT02377219 - Bisphenol A Exposure, Ovarian Function and Assisted Reproductive Technology Outcome. N/A
Recruiting NCT02644304 - Clomiphene Citrate Plus Cabergoline in Treatment of Polycystic Ovary Syndrome Phase 2